Centene Analyzes 2026 Medicaid Acuity Drivers and 2027 OB3 Outlook

Medicaid acuity change drivers and how 2026 shifts could affect 2027 outlook (including potential OB3 impact)

1) What is driving Medicaid acuity changes (Centene’s view)

A. “Low/zero-utilizer” dynamics after the PHE unwind, especially in the Medicaid expansion population

Centene highlights that utilization has been moving as the system comes off the Public Health Emergency (PHE): low/“0 utilizing” members declined from the PHE period toward pre-PHE levels, and the drop is “most pronounced” in the Medicaid expansion population. ¹ This creates an acuity profile that tends to look worse than the PHE-era mix even if overall program policy is unchanged. ¹

B. Attrition and “tightening” by states as OB3 preparation starts (possible pull-forward)

In Q2, Centene observed “slight incremental attrition” versus expectations, with some of that driven by specific changes, and also by states “tighten[ing] in general” as they start preparing for OB3—described as “starting to think about and prepare for OB3.” ² Management explicitly connects that setup to acuity: they saw “a slight uptick acuity in Q2 around that attrition,” and they are planning to cover the acuity implications of the expected membership attrition path in the back half of 2026 using rate guidance cushion. ²

Centene also frames part of this as potentially not just forward-looking OB3 implementation but “possible… some degree of pull forward of some of the activity,” meaning states may act early (e.g., categorizing populations or discouraging enrollment that would have gone through a later work requirements process). ² Management says they are “accounting for that as we think about guidance for the back half of the year.” ²

C. Specific enrollment/eligibility cohorts under OB3-style rules: ex parte eligible vs practically eligible vs newly eligible

Centene breaks the expansion population into cohorts with different “impactability,” i.e., different likelihood that members will lose eligibility or require engagement actions. ³ They describe:

• Ex parte eligible: clear data exists (claims data / frailty algorithm) so eligibility is largely automatic. ³
• Practically eligible: members are engaged (community activities, school, caregiver roles) but must “appropriately document” those activities. ³
• Can become eligible: not currently eligible, but can become eligible via engagement and workforce/job training opportunities. ³

This matters for acuity because the degree of disruption (and thus utilization mix and cost) depends on how many members fall into the “documentation” or “newly eligible” buckets and how effectively the managed-care playbook preserves eligibility outcomes. ³

D. Rate–acuity dislocation management after PHE: more tools and different guidance environment than during redeterminations

Centene argues that the environment is different in important ways: after the PHE unwind they did not have “heavy trend in that look back base period” (i.e., less “tailwind” from prior-year utilization trend), and they also lacked “explicit guidance… in terms of mid-cycle and retro rate adjustments” during parts of the redeterminations period. ⁴ In the OB3/next-year planning context, they highlight a more workable set of tools: “different set of tools at our disposal,” and they characterize the effort as “more manageable” than what they went through with redeterminations. ⁴

Practically, this means Centene expects the industry’s ability to adjust rates to changing acuity (and to manage membership disruption) to be more feasible than in the earlier large-scale unwind. ⁴

2) How 2026 acuity shifts are expected to influence the 2027 outlook

A. Centene expects margin recovery in Medicaid through “OB3 headwinds over the next year or 2”

Centene states it maintains the goal of “margin recovery for the Medicaid business even through the OB3 headwinds over the next year or 2.” ⁴ Management links this to execution, rate actions, and planning assumptions that include the expected acuity shift and membership attrition effects. ⁴

B. 2026 membership attrition is a key bridge variable into 2027 acuity

Centene expects full-year Medicaid membership to be down 8% to 9% versus 12/31/25 compared with a prior view of down 6%. ⁵ The company also notes that the business has “good signs of medical expense execution coupled with progress on rates,” while acknowledging “more work” remains over the next couple of years to restore margin. ⁵

This is important because acuity shifts tend to worsen when:

• lower-utilizing cohorts leave the pool, and/or ¹
• eligibility “tightening” increases disruption among less-utilizing members first, raising remaining average utilization/cost. ²¹

Centene is explicitly planning for “additional attrition [to] impact acuity” and says it has “set guidance to account for that possibility in the second half of 2026.” ⁶

C. Centene explicitly characterizes some 2026 activity as “pull forward” of OB3-related impacts

For the “back half of ’26” and into rate cohorts around 7/1, management says the company sees “some degree of pull forward of the OB3 impact.” ⁷ They describe collision of factors in back half 2026: membership attrition and OB3 impact pull-forward, while also benefiting from rate development/tailwind effects (not necessarily explicit OB3 inputs into rates yet). ⁷

For 2027 outlook, this implies that:

• Part of the acuity deterioration risk may already show up in 2026, reducing the incremental surprise in 2027 (though it doesn’t eliminate it). ⁷
• However, management still expects “OB3 headwinds” to persist “over the next year or 2,” so 2027 likely still includes incremental pressure from the expansion cohort and verification/compliance dynamics. ⁴

D. Rate actions with mid-cycle/next-year reconciliation are intended to cover rate–acuity changes

Centene says some states included explicit factors for OB3 in “7/1 rate cohort,” but “all of them have committed to looking at those rates 1/1/27 and thinking about mid-cycle adjustments” as the impacts come into the year. ⁷ They also note for the expansion population that rates would be “reconsidered at that interim point in 1/1, really before much of the impact were to occur.” ⁸

So the 2026 acuity shifts may matter for the timing of rate adjustments:

• 2026 experience informs what acuity patterns look like in near-real-time,
• and 1/1/27 re-rating is intended to realign rates to the new acuity/mix before 2027 impacts fully materialize. ⁷⁸

3) Potential OB3 impact in 2027: what Centene implies, and what it is managing

A. Expansion cohort shrinkage in 2026 is the main “tracked” funnel for OB3-related acuity shift

Centene states the expansion population is historically ~20% of membership, at “June 30, 19%,” and it expects to end at “roughly 18%.” ⁸ It also discusses that if 25% to 40% of that expansion population rolls off, it implies “mid-single-digit attrition” over ’27-’29 (possibly delayed if states delay). ⁹

That matters for OB3 in 2027 because OB3 implementation is specifically tied to Medicaid expansion eligibles’ verification/eligibility mechanics and documentation requirements. ³¹⁰ While the exact legal mechanism is outside the excerpts, Centene’s operational planning indicates that expansion membership changes are the company’s primary driver of the acuity bridge. ⁸⁹

B. Operational mitigation: near-real-time eligibility data and member outreach to reduce disruption risk

Centene describes deep planning with states to maximize data and reduce “coverage disruption” for eligible members. ¹⁰ It also invests in “near real-time data exchange with states to form ex parte member eligibility, exemption validation and member outreach,” and runs a nationwide playbook (community engagement, education, workforce opportunities) to support members through OB3 implementation. ⁶

This operational posture reduces the probability that 2027 sees an abrupt membership drop that would create an unfavorable acuity mix. ⁶¹⁰

C. The 2026 acuity shifts appear intended to be “covered” by guidance cushions into the 2027 transition

Centene previously held a “50 basis points” rate benefit cushion in guidance due to higher expected attrition and the move “from 6% to 8% to 9%” impacting acuity in the back half of 2026. ² In other words, management is treating 2026 acuity deterioration as a measurable input to rate-margin planning rather than an unknown. ²⁶

D. But 2027 still includes OB3 headwinds and margin recovery is not assumed automatic

Even while emphasizing manageability, Centene still frames OB3 as creating “headwinds over the next year or 2,” and it says it’s “going to try to improve” margins through execution “even through the headwinds of OB3.” ⁴⁹ That means 2026 acuity shifts may partially “front-load” risk (pull-forward) but do not fully remove 2027 exposure. ⁷⁴

4) Bottom-line synthesis (answering the question directly)

1. Drivers of Medicaid acuity changes in Centene’s reporting are primarily:

   • the post-PHE decline in low/0 utilizers, most pronounced in the Medicaid expansion population, ¹
   • state tightening and OB3 preparation that increases membership attrition and creates slight Q2 acuity upticks, ²
   • and the composition/impactability of expansion cohorts (ex parte vs practically eligible vs newly eligible), which affects disruption risk and member utilization mix. ³

2. How 2026 acuity shifts influence the 2027 outlook:

   • Centene expects back-half 2026 attrition to affect acuity and says its guidance accounts for it. ⁶
   • It characterizes some of the OB3-related activity as potential “pull forward” into 2026, so part of the acuity pressure may already be visible before 2027. ²⁷
   • Rate setting is expected to incorporate 7/1 and then “1/1/27” reconsideration (including mid-cycle adjustments) as impacts arrive, which is meant to manage the rate–acuity dislocation risk. ⁷⁸

3. Potential OB3 impact in 2027 (including “OB3 impact next year” mechanics):

   • Centene is not assuming OB3 is “already done”; it still expects OB3 headwinds to persist and maintains its goal of Medicaid margin recovery despite those headwinds. ⁴
   • The company’s mitigation focus for 2027 hinges on expansion cohort dynamics (expansion population shrinking from ~19% mid-2026 toward ~18% year-end) and on operational tools to minimize eligibility disruption through OB3 implementation. ⁸⁶
   • Net-net, Centene appears to view 2026 acuity shifts as both (a) a measurable risk already being planned for and (b) a bridge input that informs how rates will be adjusted into 1/1/27 to reduce the chance that OB3 in 2027 creates an unmanaged margin hit. ²⁶⁷⁸